{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Business News Today is your daily source for the latest headlines and stories shaping the world of business, finance, and the global economy. From market trends and corporate earnings to startups, entrepreneurship, technology, real estate, consumer trends, and economic policy, we bring you the business news that matters most—in just a few minutes. Whether you're an entrepreneur, investor, executive, business owner, or simply someone who wants to stay informed, Business News Today delivers clear, concise updates to help you understand the forces shaping the economy and the future of business. Business News Today — Business news, all in one place. Powered by AI.","last_synced_at":"2026-09-17T06:21:31.382927+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"J&J Aims to Cure or Control Cancer in 10 Years","slug":"j-j-aims-to-cure-or-control-cancer-in-10-years","published_at":"2026-06-16T17:09:25+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/j-j-aims-to-cure-or-control-cancer-in-10-years","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/044f3709-5e00-41ac-b20d-678d5c87afaa.mp3","audio_url":"https://api.fastcast.ai/audio/044f3709-5e00-41ac-b20d-678d5c87afaa.mp3","summary":"J&J’s CEO Joaquin Duato unveiled a bold 10-year plan to either cure or manage certain cancers like chronic diseases, aiming for oncology dominance by 2030. Fueling this mission, J&J is leveraging AI to turbocharge drug development and just acquired Firefly Bio for $1 billion to gain its revolutionary Firelink platform—targeting deadly KRAS-mutated tumors with precision therapy that could slash patient suffering and expand their pipeline dramatically. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/2525b7794165c8b9","meta_description":"J&J’s CEO Joaquin Duato unveiled a bold 10-year plan to either cure or manage certain cancers like chronic diseases, aiming for oncology dominance by…","key_points":[],"chapters":[],"topics":[],"duration_seconds":113,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/j-j-aims-to-cure-or-control-cancer-in-10-years/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/j-j-aims-to-cure-or-control-cancer-in-10-years.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}